The significance of the J-curve in hypertension and coronary artery diseases

Korean Circulation Journal

Volumn 41, Issue 7, 2011, Pages 349-353

  Park, Chang Gyu ^a   Lee, Ju Young ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Coronary artery disease; Diastolic pressure; Hypertension; J curve; Stroke; Systolic pressure

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; OLMESARTAN; VERAPAMIL;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR RISK; CARDIOVASCULAR SYMPTOM; CLINICAL EVALUATION; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FOLLOW UP; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART STROKE VOLUME; HUMAN; HYPERTENSION; J CURVE PHENOMENON; KIDNEY DISEASE; KIDNEY PERFUSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVASCULARIZATION; REVIEW; STROKE; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE;

EID: 80051971301     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2011.41.7.349     Document Type: Review

References (27)

1. Frank E. Deutsches archiv fur klin. Medizin 1911;103:397-412.
2. White P. Heart Disease. 1st ed. New York: McMillan; 1931.
3. Grossman E, Messerli FH, Grodzicki T, Kowey P. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? JAMA 1996;276:1328-31.
4. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-13. (Pubitemid 35472129)
5. Stewart IM. Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension. Lancet 1979;1:861-5.
6. Cruickshank JM, Thorp JM, Zacharias EJ. Benefits and potential harm of lowering high blood pressure. Lancet 1987;1:581-4.
7. Farnett L, Muldrow CD, Linn WD, Lucey CR, Tuley MR. The J-curve phenomenon and the treatment of hypertension: is there a point beyond which pressure reduction is dangerous? JAMA 1991;265:489-95.
8. Bellamy RF. Diastolic coronary artery pressure flow relations in the dog. Circ Res 1978;43:92-101. (Pubitemid 8390251)
9. Pijls NHJ, De Bruyne B. Pitfalls in coronary pressure measurements. In: Coronary pressure. Dortrecht: Kluwer Academic Publishers; 1997. p. 105-8.
10. Harrison DG, Florentine MS, Brooks LA, Cooper SM, Marcus ML. The effect of hypertension and left ventricular hypertrophy on the lower range of coronary autoregulation. Circulation 1988;77:1108-15.
11. Polese A, De Cesare N, Montorsi P, et al. Upward shift of the lower range of coronary flow autoregulation in hypertensive patients with hypertrophy of the left ventricle. Circulation 1991;83:845-53.
12. Hakala SM, Tilvis RS. Determinants and significance of declining blood pressure in old age: a prospective birth cohort study. Eur Heart J 1998;19:1872-8. (Pubitemid 28556658)
13. Langer RD, Criqui MH, Barrett-Connor EL, Klauber MR, Ganiats TG. Blood pressure change and survival after age 75. Hypertension 1993; 22:551-9. (Pubitemid 23292162)
14. Tervahauta M, Pekkanen J, Enlund H, Nissinen A. Change in blood pressure and 5-year risk of coronary heart disease among elderly men: the Finnish cohorts of the Seven Countries Study. J Hypertens 1994;12: 1183-9. (Pubitemid 24313835)
15. Satish S, Zhang DD, Goodwin JS. Clinical significance of falling blood pressure among older adults. J Clin Epidemiol 2001;54:961-7. (Pubitemid 32755787)
16. Somes GW, Pahor M, Shorr RI, Cushman WC, Applegate WB. The role of diastolic blood pressure when treating isolated systolic hypertension. Arch Intern Med 1991;159:2004-9.
17. Fagard RH, Staessen JA, Thijs L, et al. On-treatment diastolic blood pressure and prognosis in systolic hypertension. Arch Intern Med 2007;167:1884-91. (Pubitemid 47481484)
18. Messerli FH, Mancia G, Conti CR, et al. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med 2006;144:884-93.
19. Haller H, Ito S, Izzo JL Jr, et al. Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. N Engl J Med 2011;364: 907-17.
20. Bangalore S, Messerli FH, Wun CC, et al. J-curve revisited: an analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial. Eur Heart J 2010;31:2897-908.
21. Sleight P, Redon J, Verdecchia P, et al. Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial Study. J Hypertens 2009;27:1360-9.
22. Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial: HOT Study Group. Lancet 1998;351:1755-62. (Pubitemid 28269185)
23. Cushman WC, Evans GW, Byington RP, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010; 362:1575-85.
24. Flack JM, Neaton J, Grimm R Jr, et al. Blood pressure and mortality among men with prior myocardial infarction: Multiple Risk Factor Intervention Trial Research Group. Circulation 1995;92:2437-45.
25. Glynn RJ, L'Italien GJ, Sesso HD, Jackson EA, Buring JE. Development of predictive models for long-term cardiovascular risk associated with systolic and diastolic blood pressure. Hypertension 2002;39: 105-10. (Pubitemid 34098097)
26. Psaty BM, Furberg CD, Kuller LH, et al. Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality: the Cardiovascular Health Study. Arch Intern Med 2001; 161:1183-92. (Pubitemid 32691515)
27. Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009;27:2121-58.